Log on / register
Feedback | Support | My details
Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells.
Camirand A, Zakikhani M, Young F, Pollak M
Breast Cancer Res 2005, 7:R570-9
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Mechanisms of resistance to ErbB-targeted cancer therapeutics.
Wang Q, Greene MI
J Clin Invest 2008 Jul, 118:2389-92
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.